PTOIAIAI‘I 4 (08-12)
`Approved for use through 01131 [2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number 37901-715331
`
`.
`.
`Application Number
`
`
`
`Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`
`
`
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`El 37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`
`Inventor
`
`1
`
`Legal Name
`
`Prefix Given Name
`
` Middle Name
`
`
`Family Name
`
`Residence Information (Select One)
`0 US Residency
`Non US Residency
`Active US Military Service
`City Icottsdale
`StatelProvince
`country of Residencd
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`Postal Code
`
`
`
`Inventor
`
`
`Legal Name
`
` Given Name
`
`
`
`
`
`Residence Information (Select One) 6) US Residency
`
`Non US Residency
`
`Active US Military Service
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`Address 2
`
`Postal Code
`
`Inventor
`
`I:
`
`Legal Name
`
`I262 Willow Circle Drive
`I
`
`I 6143
`
`_Ius
`
`
`Family Name
`Middle Name
`
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`EFS Web 2.2.5
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1"00 E. Fillmore St. Apt 336
`Address 2
`I
`cm I— Staterprovince
`Postal Code
`I5oo4
`_IUS
`
`I.
`
`Inventor
`
`-
`
`
`
`
`
`Legal Name
`
`
`
`
`
`
`Prefix Given Name
`Middle Name
`Family Name
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`I 534 West 300 North
`Address 1
`I
`Address 2
`cm I— staterrovince
`Postal Code
`I 6052-8244
`_IUS
`Inventor
`
`I'N
`
`Legal Name
`
`Residence Information (Select One) © US Residency
`
`Non US Residency
`
`Active US Military Service
`
`Mailing Address of Inventor:
`
`Address 1|.655 N. MacArthur Blvd.
`Address 2
`I
`cm I— Staterprovince
`Postal Code
`I 5039
`_IUS
`Inventor
`.
`
`Ix
`
`Legal Name
`
`
`
`
`Family Namew
`Middle Name
`IEI_ — _I
`
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`_ StateIProvince
`Country of Residence_
`EFS Web 2.2.5
`
`
`
`
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`Mailing Address of Inventor:
`
`I 5485 Andorra Way
`Address 1
`I
`Address 2
`cm I— Staterprovince
`Postal Code
`[2129
`_Ius
`
`I A
`
`Inventor
`
`Legal Name
`
`
`
`
`Given Name
`Middle Name
`Family Name
`
`
`-— —I
`
`
`Residence Information (Select One) © US Residency
`Non US Residency
`Active US Military Service
`
`
`
`
`
` Address 1
`
`I . 15 W Edgemont Ave
`Address 2
`
`
`
`I
`I— Staterprovince
`
`
`US
`
` Postal Code ‘
`
`
`Mailing Address of Inventor:
`
`Inventor
`
`Legal Name
`
`
`
`Non US Residency
`Active US Military Service
`Residence Information (Select One) © US Residency
`Country of Residencé_
`City I aguna Hills
`StatelProvince
`
`
`
`
`
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`
`
`Postal Code
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`generated within this form by selecting the Add button.
`
`Add
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`|:| An Address is being provided for the correspondence Information of this application.
`Customer Number
`[6600
`EFS Web 2.2.5
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`_ Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Email Address
`
`Application Information:
`
`
`
`_ddEmail Remove Email
`
`I—I
`
`Suggested Technology Center (if any)
`
`Total Number of Drawing Sheets (if any) I_ Suggested Figure for Publication (if any) I
`Publication Information:
`
`|:| Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`El
`
`Request Not to Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`Customer Number
`
`0 Customer Number
`
`US Patent Practitioner 0 Limited Recognition (37 CFR 11.9)
`
`Domestic BenefitINationaI Stage Information:
`
`
`I6600
`
`
`
`
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
` Remove
`
`Prior Application Status
`
`
`
`
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`—I_l
`555-5525
`
`
`
`
`
`Continuity Type
`Prior Application Number
`I_l14551345
`
`EFS Web 2.2.5
`
`Filing Date (YYYY-MM-DD)
`5555—55—25
`
`Application Number
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`Attorney Docket Number
`
`
`37901-715331
`
`
`
`
`
`
`MOLECULAR PROFILING OF TUMORS
`Title of Invention
`
`
`
`
`Prior Application Status
`
`—:
`Prior Application
`Continuity Type
`Number
`I I14175781
`
`Application
`Number
`14551345
`
`I ontinuation of
`
`Filing Date
`(YYYY—MM—DD)
`If 014—02—07
`
`Patent Number
`I: 092392
`
`Issue Date
`(YYYY—MM-DD)
`I' 015—07—28
`
`.
`.
`Application
`ContInUIty Type
`Number
`l I12658770
`I ontinuation of
`14175781
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Prior Application
`
`Prior Application StatusM
`Application Number
`Continuity Type
`
`Prior Application StatusM
`Application Number
`Continuity Type
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`Filing Date
`(YYYY-M M-DD)
`If 010—02—12
`
`Patent Number
`I: 768629
`
`ISSUE Date
`(YYYY-MM-DD)
`I' 014-07-01
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`
`
`
`
`Prior Application Statusm
`Application Number
`Continuity Type
`
`
`
`
`
`
`
`
`
`Prior Application Statusm
`Application Number
`Continuity Type
`Prior Application Number
`Filing Date (YYYY-MM-DD)
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Add
`
`
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim benefit of foreign priority and to identify any prior foreign application for which priority is
`not claimed. Providing this information in the application data sheet constitutes the claim for priority as required by 35 U.S.C. 119(b)
`and 37 CFR 1.55(a)_
`
`
`
`
`
`
`EFS Web 2.2.5
`
`
`
`
`
`Priority Claimed
`
`
`
`
`Yes
`
`0 No
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`_ Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Authorization to Permit Access:
`
`X Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked if the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as—filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any US. application—as—filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`Applicant
`
`1
`
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`
`Joint Inventor
`
`o Assignee
`
`
`
`
`Q
`
`
`
`Legal Representative under 35 U.S.C. 117
`
`Person to whom the inventor is obligated to assign.
`Person who shows sufficient proprietary interest
`
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Name of the Deceased or Legally lncapacitated Inventor::|
`
`If the Applicant is an Organization check here.
`EFS Web 2.2.5
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`
`37901-715331
`
`
`
`
`
`
`
`Title of Invention
`
`MOLECULAR PROFILING OF TUMORS
`
`Mailing Address Information:
`Address 1'655 North MacArthur Blvd.
`Address 2
`I
`my
`I——I x
`com» I_—I
`I——I
`I
`
`Email Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Non-Applicant Assignee Information:
`
`
`
`
`
`
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee
`
`1
`
`Complete this section only if non-applicant assignee information is desired to be included on the patent application publication in
`accordance with 37 CFR 1.215(b). Do not include in this section an applicant under 37 CFR 1.46 (assignee, person to whom the
`inventor is obligated to assign, or person who otherwise shows sufficient proprietary interest), as the patent application publication will
`include the name of the applicant(s).
`Remove
`
`
`
`If the AssigneeIs an Organization check here.
`
`Mailing Address Information:
`
`Address 2
`city
`
`I
`I——I—
`I——I—
`
`
`
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`Add
`
`EFS Web 2.2.5
`
`

`

`PTOIAIAI14 (08-12)
`Approved for use through 0113112014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995. no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Appllcatlon Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`
`37901-715331
`
`MOLECULAR PROFILING OF TUMORS
`
`_ Title of Invention
`Additional Signature may be generated within this form by selecting the Add button.
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`W‘ Ramin Akhavan.’
`
`‘ Date (YYYY-MM-DD) I'O16—06—24
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and
`Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents. P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.5
`
`

`

`Privacy Act Statement
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or hisfher designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the US. Patent and Trademark Office may not be able to process andlor examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
` The Privacy Act of 1974 (PL. 93—579) requires that you be given certain information in connection with your submission of the attached form related to
`
`
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`EFS Web 2.2.5
`
`

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket